Xu Cheryl's Form 4 filing
60 Degrees Pharmaceuticals, Inc.SXTP · filed Sep 11, 2024
- Accession no.
- 0001213900-24-077746
- Filed
- Sep 11, 2024
- Trade date
- Aug 27, 2024
- Filing delay
- 15 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $8.50K. It was filed 15 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Xu CherylCIK 0001976957 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2024 | Common Stock | PPurchaseAcquired | +5,000 | $1.70 | +$8,500 | 41,078 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.